Botanical species · safety record

Sarcolobus globosus

The EFSA Compendium of Botanicals holds 5 constituent measurements for Sarcolobus globosus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Sarcolobus globosus Wall.

5Constituent measurements
0Safety records
3Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Rotenoids3
  • Genistin1
  • Isoflavones1

Plant parts

  • Stem5
  • stalk5

Preparations

  • Solvent extraction5

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
GenistinStem / stalkSolvent extraction—Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
IsoflavonesStem / stalkSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
RotenoidsStem / stalkSolvent extraction—Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
RotenoidsStem / stalkSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
RotenoidsStem / stalkSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Wangensteen, Helle., Miron, Anca., Alamgir, Mahiuddin., Rajia, Sultana., Samuelsen, Anne Berit., Malterud, Karl Egil. Antioxidant and 15-lipoxygenase inhibitory activity of rotenoids, isoflavones and phenolic glycosides from Sarcolobus globosus . Fitoterapia, 2006, vol. 77, no. 4, p. 290-295. DOI
  2. Wangensteen, H., Alamgir, M., Rajia, S., Samuelsen, AB., Malterud, KE. Rotenoids and isoflavones from Sarcolobus globosus. PLANTA MEDICA, 2005, vol. 71, no. 8, p. 754-758. DOI
  3. Wangensteen, Helle., Alamgir, Mahiuddin., Rajia, Sultana., Meza, Trine J., Samuelsen, Anne Berit., Malterud, Karl E. Cytotoxicity and brine shrimp lethality of rotenoids and extracts from Sarcolobus globosus . Natural product communications, 2007, vol. 2, no. 8, p. 841-844.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue